• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动态乳腺 MRI 中病变分类的药代动力学绘图。

Pharmacokinetic mapping for lesion classification in dynamic breast MRI.

机构信息

University of Utah Department of Radiology, Salt Lake City, Utah 84132, USA.

出版信息

J Magn Reson Imaging. 2010 Jun;31(6):1371-8. doi: 10.1002/jmri.22179.

DOI:10.1002/jmri.22179
PMID:20512889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4657573/
Abstract

PURPOSE

To prospectively investigate whether a rapid dynamic MRI protocol, in conjunction with pharmacokinetic modeling, could provide diagnostically useful information for discriminating biopsy-proven benign lesions from malignancies.

MATERIALS AND METHODS

Patients referred to breast biopsy based on suspicious screening findings were eligible. After anatomic imaging, patients were scanned using a dynamic protocol with complete bilateral breast coverage. Maps of pharmacokinetic parameters representing transfer constant (K(trans)), efflux rate constant (k(ep)), blood plasma volume fraction (v(p)), and extracellular extravascular volume fraction (v(e)) were averaged over lesions and used, with biopsy results, to generate receiver operating characteristic curves for linear classifiers using one, two, or three parameters.

RESULTS

Biopsy and imaging results were obtained from 93 lesions in 74 of 78 study patients. Classification based on K(trans) and k(ep) gave the greatest accuracy, with an area under the receiver operating characteristic curve of 0.915, sensitivity of 91%, and specificity of 85%, compared with values of 88% and 68%, respectively, obtained in a recent study of clinical breast MRI in a similar patient population.

CONCLUSION

Pharmacokinetic classification of breast lesions is practical on modern MRI hardware and provides significant accuracy for identification of malignancies. Sensitivity of a two-parameter linear classifier is comparable to that reported in a recent multicenter study of clinical breast MRI, while specificity is significantly higher.

摘要

目的

前瞻性研究快速动态 MRI 方案与药代动力学模型相结合是否能为鉴别经活检证实的良性病变与恶性病变提供有诊断价值的信息。

材料与方法

符合可疑筛查结果而行乳腺活检的患者符合入选条件。在进行解剖成像后,对患者进行双侧乳腺完整覆盖的动态方案扫描。将药代动力学参数图(代表转移常数(K(trans))、流出率常数(k(ep))、血浆体积分数(v(p))和细胞外细胞外体积分数(v(e)))表示的转移常数(K(trans))和流出率常数(k(ep))进行平均,用于生成基于线性分类器的受试者工作特征曲线,使用一个、两个或三个参数。

结果

78 例研究患者中的 74 例获得了活检和影像学结果。基于 K(trans)和 k(ep)的分类具有最高的准确性,受试者工作特征曲线下面积为 0.915,灵敏度为 91%,特异性为 85%,而在最近一项对类似患者人群的临床乳腺 MRI 的研究中,灵敏度分别为 88%和 68%。

结论

乳腺病变的药代动力学分类在现代 MRI 硬件上是可行的,并且为识别恶性肿瘤提供了显著的准确性。双参数线性分类器的灵敏度与最近一项临床乳腺 MRI 的多中心研究相似,而特异性则显著更高。

相似文献

1
Pharmacokinetic mapping for lesion classification in dynamic breast MRI.动态乳腺 MRI 中病变分类的药代动力学绘图。
J Magn Reson Imaging. 2010 Jun;31(6):1371-8. doi: 10.1002/jmri.22179.
2
[Diagnostic value of quantitative pharmacokinetic parameters and relative quantitative pharmacokinetic parameters in breast lesions with dynamic contrast-enhanced MRI].[动态对比增强磁共振成像定量药代动力学参数及相对定量药代动力学参数在乳腺病变中的诊断价值]
Zhonghua Yi Xue Za Zhi. 2017 Aug 1;97(29):2266-2270. doi: 10.3760/cma.j.issn.0376-2491.2017.29.007.
3
Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging.应用快门速度动态对比增强磁共振成像鉴别乳腺良恶性病变。
Radiology. 2011 Nov;261(2):394-403. doi: 10.1148/radiol.11102413. Epub 2011 Aug 9.
4
3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.3-T 动态对比增强磁共振成像在乳腺中的应用:药代动力学参数与常规动力学曲线分析。
AJR Am J Roentgenol. 2011 Dec;197(6):1498-505. doi: 10.2214/AJR.10.4665.
5
High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.高时间分辨率 DCE-MRI 提高了 BI-RADS 4 类乳腺内及周围病变的评估能力。
BMC Med Imaging. 2023 Apr 19;23(1):58. doi: 10.1186/s12880-023-01015-4.
6
Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.应用容积定量动态对比增强磁共振成像鉴别乳腺良恶性病变。
Eur Radiol. 2018 Mar;28(3):982-991. doi: 10.1007/s00330-017-5050-2. Epub 2017 Sep 19.
7
Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.应用 CAIPIRINHA-Dixon-TWIST-VIBE 技术对乳腺病变行动态对比增强 MRI 全病变直方图分析获取药代动力学参数。
J Magn Reson Imaging. 2018 Jan;47(1):91-96. doi: 10.1002/jmri.25762. Epub 2017 Jun 3.
8
Separation of benign and malignant breast lesions using dynamic contrast enhanced MRI in a biopsy cohort.在活检队列中使用动态对比增强磁共振成像对乳腺良恶性病变进行鉴别
J Magn Reson Imaging. 2017 May;45(5):1385-1393. doi: 10.1002/jmri.25501. Epub 2016 Oct 20.
9
Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions.乳腺动态对比增强磁共振成像:对比剂注射后时间对病变自动动力学评估及良恶性病变鉴别的影响
Acad Radiol. 2014 Sep;21(9):1195-203. doi: 10.1016/j.acra.2014.04.013. Epub 2014 Jul 4.
10
Lesion type and reader experience affect the diagnostic accuracy of breast MRI: a multiple reader ROC study.病变类型和阅片者经验会影响乳腺MRI的诊断准确性:一项多阅片者ROC研究。
Eur J Radiol. 2015 Jan;84(1):86-91. doi: 10.1016/j.ejrad.2014.10.023. Epub 2014 Nov 14.

引用本文的文献

1
Permeability Benchmarking: Guidelines for Comparing , , and Measurements.渗透率基准测试:比较、和测量的指南。 (注:原文中“,, and ”部分内容缺失,翻译只能按现有内容进行)
J Chem Inf Model. 2025 Feb 10;65(3):1067-1084. doi: 10.1021/acs.jcim.4c01815. Epub 2025 Jan 17.
2
The Influence of Data-Driven Compressed Sensing Reconstruction on Quantitative Pharmacokinetic Analysis in Breast DCE MRI.数据驱动的压缩感知重建对乳腺 DCE-MRI 定量药代动力学分析的影响。
Tomography. 2022 Jun 14;8(3):1552-1569. doi: 10.3390/tomography8030128.
3
Improved value of whole-lesion histogram analysis on DCE parametric maps for diagnosing small breast cancer (≤ 1 cm).基于 DCE 参数图的全病变直方图分析对诊断小乳腺癌(≤1cm)的价值改善。
Eur Radiol. 2022 Mar;32(3):1634-1643. doi: 10.1007/s00330-021-08244-7. Epub 2021 Sep 9.
4
Blood Oxygenation Level Dependent Magnetic Resonance Imaging (MRI), Dynamic Contrast Enhanced MRI, and Diffusion Weighted MRI for Benign and Malignant Breast Cancer Discrimination: A Preliminary Experience.用于鉴别乳腺良恶性肿瘤的血氧水平依赖性功能磁共振成像(MRI)、动态对比增强MRI及扩散加权MRI:初步经验
Cancers (Basel). 2021 May 17;13(10):2421. doi: 10.3390/cancers13102421.
5
Discrimination of Malignant and Benign Breast Lesions Using Quantitative Multiparametric MRI: A Preliminary Study.利用定量多参数 MRI 鉴别乳腺良恶性病变:一项初步研究。
Tomography. 2020 Jun;6(2):148-159. doi: 10.18383/j.tom.2019.00028.
6
Feasibility study of dual parametric 2D histogram analysis of breast lesions with dynamic contrast-enhanced and diffusion-weighted MRI.动态对比增强及弥散加权 MRI 双参数二维直方图分析乳腺病变的可行性研究。
J Transl Med. 2018 Nov 23;16(1):325. doi: 10.1186/s12967-018-1698-x.
7
Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials.定量成像生物标志物联盟(QIBA)关于提高多中心肿瘤试验中 DWI 和 DCE-MRI 衍生生物标志物精度的建议。
J Magn Reson Imaging. 2019 Jun;49(7):e101-e121. doi: 10.1002/jmri.26518. Epub 2018 Nov 19.
8
Impact of the Number of Iterations in Compressed Sensing Reconstruction on Ultrafast Dynamic Contrast-enhanced Breast MR Imaging.压缩感知重建迭代次数对超快速动态对比增强乳腺磁共振成像的影响。
Magn Reson Med Sci. 2019 Jul 16;18(3):200-207. doi: 10.2463/mrms.mp.2018-0015. Epub 2018 Nov 9.
9
Distinguishing benign and malignant breast tumors: preliminary comparison of kinetic modeling approaches using multi-institutional dynamic contrast-enhanced MRI data from the International Breast MR Consortium 6883 trial.鉴别乳腺良性和恶性肿瘤:使用来自国际乳腺磁共振成像联盟6883试验的多机构动态对比增强磁共振成像数据对动力学建模方法进行初步比较
J Med Imaging (Bellingham). 2018 Jan;5(1):011019. doi: 10.1117/1.JMI.5.1.011019. Epub 2018 Jan 22.
10
Prediction of low-risk breast cancer using quantitative DCE-MRI and its pathological basis.使用定量动态对比增强磁共振成像预测低风险乳腺癌及其病理基础。
Oncotarget. 2017 Nov 1;8(69):114360-114370. doi: 10.18632/oncotarget.22267. eCollection 2017 Dec 26.

本文引用的文献

1
The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T.3T 磁共振动态对比增强磁共振成像中测量药代动力学参数的准确性。
Phys Med Biol. 2010 Jan 7;55(1):121-32. doi: 10.1088/0031-9155/55/1/008.
2
Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast.时间分辨率与动态对比增强 MRI 乳腺诊断性能的关系。
J Magn Reson Imaging. 2009 Nov;30(5):999-1004. doi: 10.1002/jmri.21947.
3
The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo.磁共振快门速度可在体内区分恶性和良性乳腺肿瘤的血管特性。
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17943-8. doi: 10.1073/pnas.0711226105. Epub 2008 Nov 12.
4
System identification theory in pharmacokinetic modeling of dynamic contrast-enhanced MRI: influence of contrast injection.动态对比增强磁共振成像药代动力学建模中的系统辨识理论:对比剂注射的影响
Magn Reson Med. 2008 May;59(5):1111-9. doi: 10.1002/mrm.21575.
5
Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences.使用扰相梯度回波脉冲序列进行对比剂浓度测量时的不确定性和偏差。
Phys Med Biol. 2008 May 7;53(9):2345-73. doi: 10.1088/0031-9155/53/9/010. Epub 2008 Apr 17.
6
Measurement of pharmacokinetic parameters in histologically graded invasive breast tumours using dynamic contrast-enhanced MRI.使用动态对比增强磁共振成像测量组织学分级浸润性乳腺癌的药代动力学参数。
Br J Radiol. 2008 Feb;81(962):120-8. doi: 10.1259/bjr/98435332. Epub 2007 Dec 10.
7
Meta-analysis of MR imaging in the diagnosis of breast lesions.磁共振成像在乳腺病变诊断中的Meta分析。
Radiology. 2008 Jan;246(1):116-24. doi: 10.1148/radiol.2461061298. Epub 2007 Nov 16.
8
On the identifiability of pharmacokinetic parameters in dynamic contrast-enhanced imaging.动态对比增强成像中药代动力学参数的可识别性
Magn Reson Med. 2007 Aug;58(2):425-9. doi: 10.1002/mrm.21336.
9
MRI of tumor angiogenesis.肿瘤血管生成的磁共振成像
J Magn Reson Imaging. 2007 Aug;26(2):235-49. doi: 10.1002/jmri.20991.
10
Magnetic resonance imaging measurements of vascular permeability and extracellular volume fraction of breast tumors by dynamic Gd-DTPA-enhanced relaxometry.通过动态钆-二乙三胺五乙酸增强弛豫测量法对乳腺肿瘤的血管通透性和细胞外体积分数进行磁共振成像测量。
Magn Reson Imaging. 2007 Apr;25(3):293-302. doi: 10.1016/j.mri.2006.10.016. Epub 2006 Dec 6.